Preview complete
The prescreener preview is complete. You may now close the preview.
AI-powered
PCSK9i in AAA12
Testing a new allergic rhinitis control method for kids.
Recruiting
99 years or below
All
Fase
N/A
50 participants needed
2 Locations
Brief description of study
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Updated on
19 Feb 2024.
Study ID: TBD91
We are looking for participants to join a research study about an investigational medication for a condition called AAA12. AAA12 involves changes in blood vessels, which could lead to heart problems. The study will help us learn more about how this investigational medication affects AAA12.
To join, you must be at least 18 years old. If you have been diagnosed with AAA12, you may qualify. We will check if you meet other health criteria during the screening process.
- Study Length: The study will last about 12 months.
- Time Commitment: You will need to visit the research center 8 times.
- Purpose: To understand how the investigational medication works for AAA12.
If you decide to participate, you will receive the investigational medication and be monitored by healthcare professionals. Your safety is our top priority. If you're interested, please contact us to learn more and see if you qualify. Thank you for considering joining our study!
Pre-Screener
